XML 21 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Series A Preferred Stock
Common Stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Balance at Dec. 31, 2018 $ 1 $ 9 $ 30,272 $ (73) $ (29,997) $ 212
Balance, Shares at Dec. 31, 2018 910 8,957,550        
Amounts that were allocated to recognition of the right for future investment and warrants - 2016 Loan (See Note 8) 637 637
Amounts that were allocated to recognition of the right for future investment and warrants - 2017 Loan (See Note 8) 962 962
Issuance of Common Stock and warrants for cash (Note 13n) $ 2 548 550
Issuance of Common Stock and warrants for cash (Note 13n), Shares 2,037,037        
Issuance of Common Stock and warrants due to 2016 Loan and 2017 Loan repayment (Note 13e) $ 3 991 994
Issuance of Common Stock and warrants due to 2016 Loan and 2017 Loan repayment (Note 13e), Shares 2,816,196        
Terms modification and cancellation of existing financial instruments due to 2016 and 2017 loan repayment (Note 8e) (135) (135)
Issuance of Common Stock (Note 13b) $ 1 764 765
Issuance of Common Stock (Note 13b), Shares 900,000        
Conversion of Preferred stock into Common Stock (Note 13c) $ (1) $ 1
Conversion of Preferred stock into Common Stock (Note 13c), Shares (732) 732,000        
Deemed dividend due to exercise price adjustment of warrants as a result of certain down-round anti-dilution protection or price protection features included in the warrants (Note 13) 267 (267)
Deemed dividends with respect to the repurchase of right for future investment (See Note 8) (185) (185)
Stock-based compensation 818 818
Stock-based compensation, Shares 430,345        
Net loss (3,450) (3,450)
Balance at Dec. 31, 2019 [1] $ 16 34,491 (73) (33,899) 535
Balance, Shares at Dec. 31, 2019 178 15,873,128        
Issuance of shares with respect to exercise of warrants (Notes 13p, 13q) $ 17 (17)
Issuance of shares with respect to exercise of warrants (Notes 13p, 13q), Shares 16,332,654        
Deemed dividend due to exercise price adjustment of warrants (Notes 13p, 13q) 390 (390)
Stock-based compensation 246     246
Stock-based compensation, Shares 577,713        
Net loss (4,929) (4,929)
Balance at Dec. 31, 2020 [1] $ 33 $ 35,110 $ (73) $ (39,218) $ (4,148)
Balance, Shares at Dec. 31, 2020 178 32,783,495        
[1] Representing amount less than $1